scholarly journals Circulating Cell-Free Human Papillomavirus DNA as a Marker of Treatment Outcome in Patients With HPV-Positive Squamous Cell Head and Neck Cancer After Radio(chemo) Therapy

Author(s):  
T. Rutkowski ◽  
A. Mazurek ◽  
M. Snietura ◽  
A. Wygoda ◽  
U. Bojko ◽  
...  
2018 ◽  
Author(s):  
Everett E Vokes ◽  
Kevin C. Wood

The most common histology of non-thyroid head and neck cancer is squamous cell carcinoma.  Common risk factors for head and neck malignancies include tobacco and alcohol abuse and viruses, including Epstein-Barr Virus (EBV) and Human Papillomavirus (HPV). Early stage disease is often treated with surgery or radiation therapy alone, while more advanced disease often requires a multi-modality approach including systemic chemotherapy, radiation, and surgical resection.  In the curative setting, current clinical trials are evaluating the de-escalation of therapy in HPV-releated head and neck cancer.  In the metastatic setting, clinical trials have focused on using immunotherapy agents to improve outcomes. This review chapter will discuss the etiology and common presentations of head and neck cancer, and also analyze recent advancements in the treatment of the disease.          Key words: chemoradiation, head and neck cancer, human papillomavirus, immunotherapy, oropharynx, squamous cell carcinoma, treatment deescalation


2018 ◽  
Author(s):  
Everett E Vokes ◽  
Kevin C. Wood

The most common histology of non-thyroid head and neck cancer is squamous cell carcinoma.  Common risk factors for head and neck malignancies include tobacco and alcohol abuse and viruses, including Epstein-Barr Virus (EBV) and Human Papillomavirus (HPV). Early stage disease is often treated with surgery or radiation therapy alone, while more advanced disease often requires a multi-modality approach including systemic chemotherapy, radiation, and surgical resection.  In the curative setting, current clinical trials are evaluating the de-escalation of therapy in HPV-releated head and neck cancer.  In the metastatic setting, clinical trials have focused on using immunotherapy agents to improve outcomes. This review chapter will discuss the etiology and common presentations of head and neck cancer, and also analyze recent advancements in the treatment of the disease.          Key words: chemoradiation, head and neck cancer, human papillomavirus, immunotherapy, oropharynx, squamous cell carcinoma, treatment deescalation


2007 ◽  
Vol 86 (2) ◽  
pp. 104-114 ◽  
Author(s):  
C.C.R. Ragin ◽  
F. Modugno ◽  
S.M. Gollin

Head and neck cancer was the eighth leading cause of cancer death worldwide in 2000. Although the incidence of head and neck squamous cell carcinoma (HNSCC) in the United States is relatively low, survival is poor and has not improved for several decades. While tobacco and alcohol are the primary risk factors for HNSCC development, epidemiological studies report a strong association with human papillomavirus (HPV) in a subset of HNSCC. More than 95% of cervical squamous cell carcinomas are linked to persistent HPV infection; evidence demonstrates that HPV is a necessary carcinogen. Not all HPV-positive HNSCC express the viral oncogenes ( E6 and E7), which suggests that HPV may function as a carcinogen in a smaller proportion of HNSCC. This review presents our current understanding of the relationship between HPV and HNSCC, and describes future research directions that may lead to a better understanding of the involvement of HPV in head and neck cancer.


2017 ◽  
Author(s):  
Farhoud Faraji ◽  
Munfarid Zaidi ◽  
Carole Fakhry ◽  
Daria A. Gaykalova

ABSTRACTThis review examines the general cellular and molecular underpinnings of human papillomavirus (HPV)-related carcinogenesis in the context of head and neck squamous cell carcinoma (HNSCC) and focuses on HPV-positive oropharyngeal squamous cell carcinoma in areas for which specific data is available. It covers the major pathways dysregulated in HPV- positive HNSCC and the genome-wide changes associated with this disease.


Oncogene ◽  
2019 ◽  
Vol 38 (46) ◽  
pp. 7166-7180 ◽  
Author(s):  
Joseph A. Westrich ◽  
Daniel W. Vermeer ◽  
Alexa Silva ◽  
Stephanie Bonney ◽  
Jennifer N. Berger ◽  
...  

Xenobiotica ◽  
2011 ◽  
Vol 41 (12) ◽  
pp. 1122-1130 ◽  
Author(s):  
Munindra Ruwali ◽  
Madhu Singh ◽  
Mohan C. Pant ◽  
Devendra Parmar

Sign in / Sign up

Export Citation Format

Share Document